Tissuemed announces collaboration with Medtronic for exclusive distribution of innovative neurosurgical film


Leeds based Tissuemed - a leading company in the research, development, design and manufacture of medical products based on adhesive polymer technology - has today announced that it has entered into a distribution agreement with US based Medtronic – one of the largest medical technology companies in the world.

Under the terms of its agreement, Medtronic will work in collaboration with Tissuemed to distribute Obex NeuroFilm(TM) Cerebrospinal Fluid Barrier in markets outside the US; selling the product through its direct operations and partners in most of Europe as well as other key markets.

The Obex NeuroFilm(TM) product is a synthetic ready-to-use self-adhesive barrier for cerebrospinal fluid (CSF) leak prevention. It acts as a sealant which is commonly placed over a suture line or other repaired dura resulting from a neurosurgical procedure. The film clings to tissue and bonds, forming a seal over the tissue surface within 30 seconds.

It gives surgeons the flexibility to work immediately to seal any openings from sutures or other dural repairs, helping to create a water-tight seal to prevent leakage of cerebrospinal fluid. This bioresorbable product stays where it is applied, remaining intact until it is largely absorbed in the weeks following a neurosurgical procedure.

A preclinical study has shown that the Obex NeuroFilm(TM) sealant has the potential to provide a useful adjunct in the reduction of CSF leaks during and after neurosurgical procedures.

Speaking about the collaboration Nick Woods, CEO of Tissuemed said: "Medtronic is a global leader in medical device technology and we look forward to leveraging our partnership for the benefit of surgeons and patients. We are pleased to offer this easy-to-use, innovative solution to operative challenges faced by neurosurgeons that may help improve patient outcomes."

“Going forward working with Medtronic means they can address what is currently a poorly met surgical need with a technology-based solution. We can focus our activities on both supporting that activity with new and exciting developments, while also accelerating the development of new iterations in many other surgical disciplines.”

Mark Fletcher, president of the Neuro Technologies and ENT businesses at Medtronic, added: "We are pleased to collaborate with Tissuemed to bring this revolutionary product to surgeons. The  Obex NeuroFilm product is an important strategic addition to our industry-leading portfolio of products for neurosurgeons."

More information about Tissuemed

Tissuemed, based in Leeds, UK, is a leading medical device company with a reputation for technical innovation dating back over twenty years. The company has its origins in the development of tissue-based therapeutic devices including developing the first tissue heart valve to gain regulatory approval in Europe, subsequently developing "living" vascular grafts and collagen patches. The company developed light-activated surgical adhesives for which Tissuemed was the Gold Winner of the Medical Design Excellence Award in 2001.

About the Surgical Technologies Business at Medtronic

Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world. Its Surgical Technologies business develops products for the diagnosis and treatment of chronic diseases and disorders of the ear, nose and throat; surgical devices and implantable products for the treatment of cranial, spinal and specialty small-bone conditions; and state-of-the-art navigation equipment used in operating rooms to assist physicians in neuro and spinal surgery procedures.

For more information contact Julia Price, Medilink Yorkshire and Humber:

Tel:  +44 114  2329281
E-mail: j.price@.medilink.co.uk

100% thumbs up from 2 votes cast